Erythrocyte membrane fluidity in mild cognitive impairment and Alzheimer's disease patients

Exp Gerontol. 2019 Dec:128:110754. doi: 10.1016/j.exger.2019.110754. Epub 2019 Oct 21.

Abstract

Alzheimer's disease (AD) is the most common cause of dementia accounting for 60-70% of all demented cases and one of the leading sources of morbidity and mortality in the aging population. Most of the recent literature regards the relationship between plasma oxidative stress and AD, showing that markers of lipid peroxidation are significantly higher in AD and Mild Cognitive Impairment (MCI) patients with respect to control subjects. The increased generation of reactive oxygen species that occurs in AD may be also responsible for oxidative injury to erythrocyte membranes. Since erythrocyte membrane serves as a variable barrier to oxygen transport, changes in its stability can induce cellular hypoxia and the consequence brain tissue oxygenation. In this study, plasma oxygen radical absorbance capacity (ORAC) and erythrocyte membrane fluidity have been evaluated in control, MCI and AD patients. Moreover erythrocyte membrane acetylcholinesterase (AchE) activity has been measured in control and AD patients. Plasma ORAC significantly decreased in MCI and AD subjects with respect to the controls, while a decrease in erythrocyte membrane fluidity has been observed only in MCI patients. No significant differences were detected in erythrocyte AchE activity between control subjects and AD patients.

Keywords: Alzheimer's disease; Erythrocyte membrane fluidity; Laurdan; Mild Cognitive Impairment; Oxidative stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholinesterase / metabolism
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / blood*
  • Antioxidants / metabolism
  • Cognitive Dysfunction / blood*
  • Erythrocyte Membrane / physiology*
  • Female
  • Fluorescence
  • Humans
  • Male
  • Membrane Fluidity*
  • Oxidative Stress

Substances

  • Antioxidants
  • Acetylcholinesterase